Various clinical studies have revealed that the ANGPTL2 level significantly increases in a variety of chronic inflammatory diseases and is related to the diagnosis and prognosis of chronic kidney disease, diabetes, cardiovascular diseases, and a variety of cancers [21]. This evidence concerns the gene ANGPTL2 and cancer.